Publicaciones en las que colabora con OLATZ ARRIZABALAGA GARDE (3)
2016
-
MTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Expert Opinion on Therapeutic Targets, Vol. 20, Núm. 4, pp. 393-405
-
Targeting SOX2 as a therapeutic strategy in glioblastoma
Frontiers in Oncology
2013
-
Therapeutic strategies targeting Glioblastoma stem cells
Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Núm. 3, pp. 216-227